Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03872206
Title Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Harpoon Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
University of Southern California Los Angeles California 90007 United States Details
University of California Los Angeles Los Angeles California 90095-7170 United States Details
Mayo Clinic Florida Jacksonville Florida 32224 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Washington University School of Medicine in St. Louis Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10017 United States Details
Cleveland Clinic Taussig Cancer Institute Cleveland Ohio 44195 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22903 United States Details
University of Washington Medical Center Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field